These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6199477)

  • 1. Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.
    Amrein PC; Fingert H; Weitzman SA
    J Clin Oncol; 1983 Jul; 1(7):421-7. PubMed ID: 6199477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
    Amrein PC; Weitzman SA
    J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
    Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarò P; Carlini P; Ruggeri EM; Ambesi Impiombato F; Del Vecchio MR; Giannarelli D; Perrino A
    Cancer; 1988 Jul; 62(2):251-61. PubMed ID: 2454721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.
    Rozencweig M; Dodion P; Bruntsch U; Gallmeier W; Clavel M; Gignoux B; Cortes Funes H; Cavalli F; Kirkpatrick A; Dalesio O
    Cancer; 1984 Oct; 54(8):1499-503. PubMed ID: 6206936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin.
    Hill BT; Price LA; MacRae K
    J Clin Oncol; 1986 Sep; 4(9):1340-7. PubMed ID: 3746375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
    Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
    J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
    Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
    J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
    Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
    J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I; Kawabe Y; Nakashima T; Yamagiwa M; Suzuki T; Mizuno A; Mineda H
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2567-78. PubMed ID: 1702133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and 5-fluorouracil in recurrent head and neck cancer: results of an outpatient schedule.
    Airoldi M; Pedani F; Brando V; Giordano C; Gabriele P
    Chemioterapia; 1988 Apr; 7(2):127-9. PubMed ID: 3396116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
    Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer.
    Kies MS; Gordon LI; Hauck WW; Krespi Y; Ossoff RH; Pecaro BC; Yuska C; Lamut CH; Brand WN; Chang SK
    Otolaryngol Head Neck Surg; 1985 Apr; 93(2):199-205. PubMed ID: 2581211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.